Inhibition of 11ß-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study.
Diabetes Obes Metab
; 24(5): 881-890, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35014156
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Non-alcoholic Fatty Liver Disease
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2022
Type:
Article
Affiliation country:
United States